share_log

維他奶國際：截至二零二四年一月三十一日之月報表

VITASOY INT'L: MONTHLY RETURN FOR THE MONTH ENDED 31/01/2024

香港交易所 ·  Feb 5 20:58
Summary by Moomoo AI
維他奶國際於2024年2月6日向香港交易及結算所有限公司提交了截至2024年1月31日的證券變動月報表。報告顯示，該公司在過去一個月內沒有普通股的增減變動。報告中提及的股份期權計劃包括自2014年至2023年授出的多個購股權計劃，但在2024年1月份並無新的股份期權行使，因此也沒有新股份發行。所有股份期權計劃均已於2012年8月28日的股東大會上獲得通過，唯獨2023年的股權計劃是在2022年8月30日的股東大會上通過。該報告還確認了公司在當月發行的證券已獲得董事會的正式授權，並符合香港聯合交易所有限公司證券上市規則的所有要求。
維他奶國際於2024年2月6日向香港交易及結算所有限公司提交了截至2024年1月31日的證券變動月報表。報告顯示，該公司在過去一個月內沒有普通股的增減變動。報告中提及的股份期權計劃包括自2014年至2023年授出的多個購股權計劃，但在2024年1月份並無新的股份期權行使，因此也沒有新股份發行。所有股份期權計劃均已於2012年8月28日的股東大會上獲得通過，唯獨2023年的股權計劃是在2022年8月30日的股東大會上通過。該報告還確認了公司在當月發行的證券已獲得董事會的正式授權，並符合香港聯合交易所有限公司證券上市規則的所有要求。
Vitagma International filed with Hong Kong Trading and Settlement Limited on 6 February 2024 the Monthly Securities Change Report for the year ended 31 January 2024. The report showed that the company had no change in gains and losses in ordinary shares over the past month. The share option plans referred to in the report include multiple share option plans issued from 2014 to 2023, but no new share options were exercised in January 2024 and therefore no new shares were issued. All share option plans were approved at the general meeting on August 28, 2012, and the only stock option plan for 2023 was approved at the general meeting on August 30, 2022. The report also confirmed that the securities issued by the company in the month were formally authorized by the Board of Directors and met all the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Vitagma International filed with Hong Kong Trading and Settlement Limited on 6 February 2024 the Monthly Securities Change Report for the year ended 31 January 2024. The report showed that the company had no change in gains and losses in ordinary shares over the past month. The share option plans referred to in the report include multiple share option plans issued from 2014 to 2023, but no new share options were exercised in January 2024 and therefore no new shares were issued. All share option plans were approved at the general meeting on August 28, 2012, and the only stock option plan for 2023 was approved at the general meeting on August 30, 2022. The report also confirmed that the securities issued by the company in the month were formally authorized by the Board of Directors and met all the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more